Evidence map›Paper›PMID 32716505›Full record

ArticleHuman molecular genetics2020

Multiplex melanoma families are enriched for polygenic risk.

Matthew H Law, Lauren G Aoude, David L Duffy, Georgina V Long, Peter A Johansson, Antonia L Pritchard, Kiarash Khosrotehrani, Graham J Mann, Grant W Montgomery, Mark M Iles and 12 more

Open access · greenAbstract read
In one paragraph

Article in Human molecular genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Melanoma susceptibility: an update on genetic and epigenetic findings.International journal of molecular epidemiology and genetics · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 2 countries.

Matthew H LawStatistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
Lauren G AoudeOncogenomics, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
David L DuffyGenetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
Georgina V LongMelanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia.
Peter A JohanssonOncogenomics, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
Antonia L PritchardOncogenomics, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
Kiarash KhosrotehraniExperimental Dermatology Group, The University of Queensland Diamantina Institute, The University of Queensland, Brisbane, QLD 4102, Australia.
Graham J MannMelanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia.
Grant W MontgomeryMolecular Biology, The University of Queensland, Brisbane, QLD 4072, Australia.
Mark M IlesLeeds Institute for Medical Research, University of Leeds, Leeds LS2 9JT, UK.
Anne E CustMelanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia.
Jane M PalmerOncogenomics, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
Melanoma GWAS Consortium
Kerwin F ShannonMelanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia.
Andrew J SpillaneMelanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia.
Jonathan R StretchMelanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia.
John F ThompsonMelanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia.
Robyn P M SawMelanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia.
Richard A ScolyerMelanoma Institute Australia, The University of Sydney, Sydney, NSW 2065, Australia.
Nicholas G MartinGenetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
Nicholas K HaywardOncogenomics, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
Stuart MacGregorStatistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.
The University of Sydney · AUQIMR Berghofer Medical Research Institute · AUThe University of Queensland · AUUniversity of Leeds · GB

Funding

Wellcome Trust WT084766/Z/08/Z
6 · The paper itself

Abstract

Cancers, including cutaneous melanoma, can cluster in families. In addition to environmental etiological factors such as ultraviolet radiation, cutaneous melanoma has a strong genetic component. Genetic risks for cutaneous melanoma range from rare, high-penetrance mutations to common, low-penetrance variants. Known high-penetrance mutations account for only about half of all densely affected cutaneous melanoma families, and the causes of familial clustering in the remainder are unknown. We hypothesize that some clustering is due to the cumulative effect of a large number of variants of individually small effect. Common, low-penetrance genetic risk variants can be combined into polygenic risk scores. We used a polygenic risk score for cutaneous melanoma to compare families without known high-penetrance mutations with unrelated melanoma cases and melanoma-free controls. Family members had significantly higher mean polygenic load for cutaneous melanoma than unrelated cases or melanoma-free healthy controls (Bonferroni-corrected t-test P = 1.5 × 10-5 and 6.3 × 10-45, respectively). Whole genome sequencing of germline DNA from 51 members of 21 families with low polygenic risk for melanoma identified a CDKN2A p.G101W mutation in a single family but no other candidate high-penetrance melanoma susceptibility genes. This work provides further evidence that melanoma, like many other common complex disorders, can arise from the joint action of multiple predisposing factors, including rare high-penetrance mutations, as well as via a combination of large numbers of alleles of small effect.

Indexed as

Genetic Predisposition to DiseasePenetranceAllelesCutaneous Malignant MelanomaCyclin-Dependent Kinase Inhibitor p16FemaleGerm-Line MutationHumansMaleMelanomaMultifactorial InheritanceMutationSkin NeoplasmsUltraviolet RaysCDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p16

Identifiers

PMID32716505
PMCPMC7566496
OpenAlexW3045578849

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.